Mr. Stanley leads the pioneering company focused on developing a multi-compound, hemp-derived drug for autism spectrum disorder. As a co-founder and former COO of Charlotte’s Web, Jared played a crucial role in establishing the company as a leader in the CBD industry, having an instrumental role in the patented hemp genetics that are the foundation of DeFloria’s R+D and the pharma-grade manufacturing practices that will serve the commercialization of the drug. His extensive experience in cannabis operations and innovation has been instrumental in advancing DeFloria's clinical trials and product development. Jared's leadership continues to shape the future of botanical medicine, leveraging his deep knowledge and passion for plant-based therapies.